技术指标
指标
数值
方向
MACD(12,26,9)
-2.595
卖出
RSI(14)
42.491
中性
STOCH(KDJ)(9,3,3)
17.317
中性
ATR(14)
7.129
低波动
CCI(14)
-96.203
中性
Williams %R
94.786
超卖
TRIX(12,20)
0.015
卖出
StochRSI(14)
0.000
超卖
搜索
瑞思迈
RMD添加自选
191.890USD
-1.020-0.53%
收盘 07-23 16:00（美东）报价延迟15分钟
27.83B总市值
18.43市盈率 TTM
关键数据
190.450今开
192.510最高
1.01M成交量
18.43市盈率 TTM
16.14市盈率动
2.330股息TTM
0.70%换手率
192.910昨收
190.210最低
88.92M成交额
19.87市盈率静
4.29市净率
1.21%股息率 TTM
18.59%ROA
293.81052周最高
0.93量比
1.40B净利润
145.04M总股本
10.4102每股收益TTM
0.83Beta
25.25%ROE
198.61052周最低
1.19%振幅
61.46%毛利率
27.83B总市值
-1.26回报/风险
1.45%风险率
TradingKey 瑞思迈股票评分
单位: USD 更新时间: 2026-07-23操作建议
瑞思迈当前公司基本面数据相对非常健康，增长潜力很大。当前估值合理，在医疗设备与耗材行业排名26/200位。机构持股占比非常高，近一月多位分析师给出公司评级为持有。最高目标价247.97。中期看，股价处于下降通道。近一个月，市场表现一般，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
瑞思迈评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
35°C
过冷
过热
看空
瑞思迈亮点
亮点风险
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
业绩高增长
公司营业收入稳步增长，连续3年增长21.86%
利润高增长
公司净利润处于行业前列，最新年度总收入5.15B美元
高分红
公司属于高分红公司，最新股息支付率22.19%
稳定分红
公司5年内连续分红，最新股息支付率22.19%
估值低估
公司最新PE估值18.43，处于3年历史低位
机构减仓
最新机构持股100.10M股，环比减少1.39%
雷·达里奥持仓
明星投资者雷·达里奥持仓，最新持仓市值42.60K
分析师目标
根据
21
位分析师
持有
评级
247.967
目标均价
+26.64%
涨幅空间
收益预测
分析师评级
根据
21
位分析师
持有
评级
247.967
目标均价
+26.64%
涨幅空间
强力买入
买入
持有
卖出
强力卖出
同行比较
88
总数
4
中位数
7
平均值
公司名称
评级分布
分析师数
瑞思迈
RMD
21
波士顿科学
BSX
37
直觉外科
ISRG
35
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
30
赛默飞世尔科技
TMO
30
1
2
3
...
18
技术指标
移动平均线
指标
数值
方向
MA5
195.640
卖出
MA10
197.491
卖出
MA20
201.514
卖出
MA50
198.848
卖出
MA100
212.902
卖出
MA200
234.155
卖出
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
瑞思迈简介
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
公司代码RMD
公司瑞思迈
CEOFarrell (Michael J)
网址https://www.resmed.com/
公司股东
相关品种
-1.77%
+8.73%
+0.22%
-1.08%
+7.39%
+3.22%
-2.54%
+0.18%
+1.33%
-2.54%
+0.46%
+1.44%
+1.48%
-0.68%
-0.78%
-0.99%
-0.14%
+4.72%
+3.15%
+0.12%热门品种
常见问题
瑞思迈(RMD)的当前股价是多少？
瑞思迈(RMD)的当前股价是 191.89。
瑞思迈的股票代码是什么？
瑞思迈的股票代码是RMD。
瑞思迈股票的52周最高点是多少？
瑞思迈股票的52周最高点是293.81。
瑞思迈股票的52周最低点是多少？
瑞思迈股票的52周最低点是198.61。
瑞思迈的市值是多少？
瑞思迈的市值是27.83B。
现在瑞思迈(RMD)的股票是买入、持有还是卖出？
根据分析师评级，瑞思迈(RMD)的总体评级为signal_hold，目标价格为247.97。
瑞思迈(RMD)股票的每股收益（EPS TTM）是多少
瑞思迈(RMD)股票的每股收益（EPS TTM）是9.55。